Coinfection by human immunodeficiency virus and hepatitis C virus
Authors:
- Salvador ResinoSRSalvador Resino
- Matilde Sánchez-CondeMatilde Sánchez-Conde
- Juan BerenguerJBJuan Berenguer
- 1 October 2012
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Infectious Diseases
- Vol. 25 (5) , 564-569
Abstract
This review presents recent findings on noninvasive alternatives for the diagnosis of fibrosis and cirrhosis in patients who are coinfected with HIV and hepatitis C virus (HCV). APRI, FIB-4, and Forns were accurate indices for the diagnosis of cirrhosis [area under the receiver operating characteristic curve (AUROC) >0.80] but not for the diagnosis of significant and advanced fibrosis (AUROC < 0.80). Diagnostic accuracy was affected by CD4 T-cell count and alanine aminotransferase levels. An artificial neural network to predict significant fibrosis was highly accurate (AUROC of 0.853), outperforming simple noninvasive indices. Derivations of the FibroMeter panel (FibroMeter HICV and FibroMeter HICV) achieved high diagnostic accuracy for significant fibrosis (AUROC of 0.823 and 0.833, respectively). Transient elastography had higher predictive accuracy than previously validated panels for diagnosis of advanced fibrosis (F ≥ 3) and cirrhosis (0.93 and 0.99, respectively). However, misclassification as F ≥ 3 was more common among patients with steatosis than among those without steatosis (25 versus 5%, P = 0.01). Moreover, transient elastography can predict clinically significant and severe portal hypertension in HIV/HCV-coinfected patients. Both biomarkers and transient elastography can accurately diagnose fibrosis and cirrhosis and are better at excluding than at predicting liver disease in HIV/HCV-coinfected patients.Keywords
This publication has 43 references indexed in Scilit:
- 2011 European Association of the Study of the Liver hepatitis C virus clinical practice guidelinesLiver International, 2011
- The natural history of liver cirrhosis in HIV–hepatitis C virus-coinfected patientsAIDS, 2011
- Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver diseaseBest Practice & Research Clinical Gastroenterology, 2011
- How to assess liver fibrosis in chronic hepatitis C: serum markers or transient elastography vs. liver biopsy?Liver International, 2011
- Noninvasive assessment of liver fibrosisHepatology, 2010
- Fast Fibrosis Progression Between Repeated Liver Biopsies in Patients Coinfected with Human Immunodeficiency Virus/Hepatitis C Virus†Hepatology, 2009
- Management Complexities of HIV/Hepatitis C Virus Coinfection in the Twenty-First CenturyClinics in Liver Disease, 2008
- Management of Chronic Hepatitis C Virus Infection in HIV‐Infected PatientsClinical Infectious Diseases, 2008
- Diagnosis and Management of Cirrhosis in Coinfected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2007
- An Algorithm for the Grading of Activity in Chronic Hepatitis CHepatology, 1996